| Entry |
|
|---|
| Name |
Emiglitate (JAN/INN) |
|---|
| Formula |
C17H25NO7
|
|---|
| Exact mass |
355.1631
|
|---|
| Mol weight |
355.38
|
|---|
| Structure |
|
|---|
| Class |
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01663 alpha-Glucosidase inhibitor
|
|---|
| Efficacy |
Antidiabetic, alpha-Glucosidase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
| hsa04973 | Carbohydrate digestion and absorption |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01663 alpha-Glucosidase inhibitor
D09779 Emiglitate
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Glycosidases
GAA
D09779 Emiglitate (JAN/INN)
GANC
D09779 Emiglitate (JAN/INN)
MGAM
D09779 Emiglitate (JAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 25
1 C1y C 32.0600 -22.6100
2 C1y C 32.0600 -24.0100
3 C1y C 33.2724 -24.7100
4 C1y C 34.4849 -24.0100
5 C1x C 34.4849 -22.6100
6 N1y N 33.2724 -21.9100
7 C1b C 30.8476 -21.9100
8 O1a O 29.6521 -22.6004
9 O1a O 30.8476 -24.7100
10 O1a O 33.2724 -26.1098
11 O1a O 35.7160 -24.7210
12 C1b C 33.2724 -20.5102
13 C1b C 34.4680 -19.8198
14 O2a O 34.4682 -18.4103
15 C8y C 35.6595 -17.7224
16 C8x C 36.8444 -18.4065
17 C8x C 38.0569 -17.7065
18 C8y C 38.0569 -16.3065
19 C8x C 36.8720 -15.6224
20 C8x C 35.6595 -16.3224
21 C7a C 39.2850 -15.5973
22 O7a O 40.4916 -16.2938
23 O6a O 39.2847 -14.2101
24 C1b C 41.6733 -15.6114
25 C1a C 42.8676 -16.3010
BOND 26
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 1 7 1 #Up
8 7 8 1
9 2 9 1 #Down
10 3 10 1 #Up
11 4 11 1 #Down
12 6 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 18 19 1
20 19 20 2
21 15 20 1
22 18 21 1
23 21 22 1
24 21 23 2
25 22 24 1
26 24 25 1
|
|---|
